Showing results (41-50 of 434) with videos related to
Sort By:
Pageof 44
Current Treatment Options in Oncology|April 18, 2006
Novel treatment approaches for patients with relapsed and refractory multiple myelomaRajni Sinha, Sagar LonialCancer|April 16, 2019
Is there still a role for stem cell transplantation in multiple myeloma?Roberto Mina, Sagar LonialSeminars in Oncology|May 5, 2004
Multiple myeloma: the role of transplant and novel treatment strategiesJonathan Kaufman, Sagar LonialExpert Review of Hematology|November 14, 2012
Sequential or combination therapy for multiple myelomaAjay Nooka, Sagar LonialBlood Cancer Journal|September 13, 2024
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patientsNisha S Joseph, Jonathan L Kaufman, Vilas A Gupta, et al.Expert Opinion on Investigational Drugs|September 8, 2005
Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004Maureen Haas, Sagar LonialJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple MyelomaNisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, et al.Transplantation and Cellular Therapy|October 9, 2021
Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of LifeNisha S Joseph, Vikas A Gupta, Sarah Wyman, et al.Cancer|April 6, 2019
Daratumumab in multiple myelomaAjay K Nooka, Jonathan L Kaufman, Craig C Hofmeister, et al.Drugs|August 9, 2003
Breakthroughs in the management of multiple myelomaLeonard T Heffner, Sagar LonialPageof 44